Summary

The global Small Molecule Drug CDMO Services market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Small molecule drug CDMO services refer to outsourcing services for the development and production of small molecule drugs. CDMO (Contract Development and Manufacturing Organization) is a third-party organization that specializes in drug development and production. It provides customized services to pharmaceutical companies, covering the entire process from the drug development stage to the commercial production stage. CDMO services for small molecule drugs usually include drug development support, clinical trial support, production process optimization, commercial production, quality control and compliance support. By choosing CDMO services, pharmaceutical companies can focus on their core business and outsource drug R&D and production to professional organizations, thereby improving efficiency, reducing risks, and accelerating the launch of new drugs.
In 2025, the North America Small Molecule Drug CDMO Services market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Small Molecule Drug CDMO Services include Gliead, Boehringer Ingelheim, Vertex, Mirati Therapeutics, AMPAC, Pfizer, Polypeptide, Bachem, Merck, Asymchem, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Small Molecule Drug CDMO Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Thermo Fisher Scientific
Zhejiang Jiuzhou Pharmaceutical
Porton Fine Chemicals
Lonza Group
JOINN Biologics
Zhejiang Langhua Pharmaceutical
Kingchem (Liaoning) Life Science
Segment by Type
Preparation
Chemical API
Segment by Application
Clinical Treatment
Medical Research
Commercial Production
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Small Molecule Drug CDMO Services market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Small Molecule Drug CDMO Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Preparation
1.2.3 Chemical API
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Clinical Treatment
1.3.3 Medical Research
1.3.4 Commercial Production
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Small Molecule Drug CDMO Services Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Small Molecule Drug CDMO Services Market Share by Revenue, by Region (2021-2026)
2.4 Global Small Molecule Drug CDMO Services Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Small Molecule Drug CDMO Services Market Size and Prospective (2021-2032)
2.5.2 Europe Small Molecule Drug CDMO Services Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Small Molecule Drug CDMO Services Market Size and Prospective (2021-2032)
2.5.4 Latin America Small Molecule Drug CDMO Services Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Small Molecule Drug CDMO Services Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Small Molecule Drug CDMO Services Historical Market Size by Type (2021-2026)
3.2 Global Small Molecule Drug CDMO Services Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Small Molecule Drug CDMO Services

4 Breakdown Data by Application
4.1 Global Small Molecule Drug CDMO Services Historical Market Size by Application (2021-2026)
4.2 Global Small Molecule Drug CDMO Services Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Small Molecule Drug CDMO Services Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Small Molecule Drug CDMO Services Players by Revenue (2021-2026)
5.1.2 Global Small Molecule Drug CDMO Services Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Small Molecule Drug CDMO Services Revenue
5.4 Global Small Molecule Drug CDMO Services Market Concentration Analysis
5.4.1 Global Small Molecule Drug CDMO Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMO Services Revenue in 2025
5.5 Global Key Players of Small Molecule Drug CDMO Services Head Offices and Areas Served
5.6 Global Key Players of Small Molecule Drug CDMO Services, Product and Application
5.7 Global Key Players of Small Molecule Drug CDMO Services, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Small Molecule Drug CDMO Services Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Small Molecule Drug CDMO Services Market Size by Type (2021-2026)
6.1.2.2 North America Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Small Molecule Drug CDMO Services Market Size by Application (2021-2026)
6.1.3.2 North America Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
6.1.4 North America Small Molecule Drug CDMO Services Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Small Molecule Drug CDMO Services Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Small Molecule Drug CDMO Services Market Size by Type (2021-2026)
6.2.2.2 Europe Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Small Molecule Drug CDMO Services Market Size by Application (2021-2026)
6.2.3.2 Europe Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
6.2.4 Europe Small Molecule Drug CDMO Services Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Small Molecule Drug CDMO Services Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Small Molecule Drug CDMO Services Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Small Molecule Drug CDMO Services Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Small Molecule Drug CDMO Services Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Small Molecule Drug CDMO Services Market Size by Type (2021-2026)
6.4.2.2 Latin America Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Small Molecule Drug CDMO Services Market Size by Application (2021-2026)
6.4.3.2 Latin America Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
6.4.4 Latin America Small Molecule Drug CDMO Services Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Small Molecule Drug CDMO Services Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Small Molecule Drug CDMO Services Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Small Molecule Drug CDMO Services Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 Gliead
7.1.1 Gliead Company Details
7.1.2 Gliead Business Overview
7.1.3 Gliead Small Molecule Drug CDMO Services Introduction
7.1.4 Gliead Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.1.5 Gliead Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Details
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Small Molecule Drug CDMO Services Introduction
7.2.4 Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.2.5 Boehringer Ingelheim Recent Development
7.3 Vertex
7.3.1 Vertex Company Details
7.3.2 Vertex Business Overview
7.3.3 Vertex Small Molecule Drug CDMO Services Introduction
7.3.4 Vertex Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.3.5 Vertex Recent Development
7.4 Mirati Therapeutics
7.4.1 Mirati Therapeutics Company Details
7.4.2 Mirati Therapeutics Business Overview
7.4.3 Mirati Therapeutics Small Molecule Drug CDMO Services Introduction
7.4.4 Mirati Therapeutics Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.4.5 Mirati Therapeutics Recent Development
7.5 AMPAC
7.5.1 AMPAC Company Details
7.5.2 AMPAC Business Overview
7.5.3 AMPAC Small Molecule Drug CDMO Services Introduction
7.5.4 AMPAC Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.5.5 AMPAC Recent Development
7.6 Pfizer
7.6.1 Pfizer Company Details
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Small Molecule Drug CDMO Services Introduction
7.6.4 Pfizer Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.6.5 Pfizer Recent Development
7.7 Polypeptide
7.7.1 Polypeptide Company Details
7.7.2 Polypeptide Business Overview
7.7.3 Polypeptide Small Molecule Drug CDMO Services Introduction
7.7.4 Polypeptide Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.7.5 Polypeptide Recent Development
7.8 Bachem
7.8.1 Bachem Company Details
7.8.2 Bachem Business Overview
7.8.3 Bachem Small Molecule Drug CDMO Services Introduction
7.8.4 Bachem Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.8.5 Bachem Recent Development
7.9 Merck
7.9.1 Merck Company Details
7.9.2 Merck Business Overview
7.9.3 Merck Small Molecule Drug CDMO Services Introduction
7.9.4 Merck Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.9.5 Merck Recent Development
7.10 Asymchem
7.10.1 Asymchem Company Details
7.10.2 Asymchem Business Overview
7.10.3 Asymchem Small Molecule Drug CDMO Services Introduction
7.10.4 Asymchem Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.10.5 Asymchem Recent Development
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Details
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Small Molecule Drug CDMO Services Introduction
7.11.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.11.5 Thermo Fisher Scientific Recent Development
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
7.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.12.3 Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Introduction
7.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
7.13 Porton Fine Chemicals
7.13.1 Porton Fine Chemicals Company Details
7.13.2 Porton Fine Chemicals Business Overview
7.13.3 Porton Fine Chemicals Small Molecule Drug CDMO Services Introduction
7.13.4 Porton Fine Chemicals Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.13.5 Porton Fine Chemicals Recent Development
7.14 Lonza Group
7.14.1 Lonza Group Company Details
7.14.2 Lonza Group Business Overview
7.14.3 Lonza Group Small Molecule Drug CDMO Services Introduction
7.14.4 Lonza Group Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.14.5 Lonza Group Recent Development
7.15 JOINN Biologics
7.15.1 JOINN Biologics Company Details
7.15.2 JOINN Biologics Business Overview
7.15.3 JOINN Biologics Small Molecule Drug CDMO Services Introduction
7.15.4 JOINN Biologics Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.15.5 JOINN Biologics Recent Development
7.16 Zhejiang Langhua Pharmaceutical
7.16.1 Zhejiang Langhua Pharmaceutical Company Details
7.16.2 Zhejiang Langhua Pharmaceutical Business Overview
7.16.3 Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Introduction
7.16.4 Zhejiang Langhua Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.16.5 Zhejiang Langhua Pharmaceutical Recent Development
7.17 Kingchem (Liaoning) Life Science
7.17.1 Kingchem (Liaoning) Life Science Company Details
7.17.2 Kingchem (Liaoning) Life Science Business Overview
7.17.3 Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Introduction
7.17.4 Kingchem (Liaoning) Life Science Revenue in Small Molecule Drug CDMO Services Business (2021-2026)
7.17.5 Kingchem (Liaoning) Life Science Recent Development

8 Small Molecule Drug CDMO Services Market Dynamics
8.1 Small Molecule Drug CDMO Services Industry Trends
8.2 Small Molecule Drug CDMO Services Market Drivers
8.3 Small Molecule Drug CDMO Services Market Challenges
8.4 Small Molecule Drug CDMO Services Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Small Molecule Drug CDMO Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Small Molecule Drug CDMO Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Small Molecule Drug CDMO Services Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Small Molecule Drug CDMO Services Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Small Molecule Drug CDMO Services Revenue Share by Region (2021-2026)
Table 6. Global Small Molecule Drug CDMO Services Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Small Molecule Drug CDMO Services Revenue Share Forecast by Region (2027-2032)
Table 8. Global Small Molecule Drug CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Small Molecule Drug CDMO Services Market Share by Revenue, by Type (2021-2026)
Table 10. Global Small Molecule Drug CDMO Services Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Small Molecule Drug CDMO Services Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Small Molecule Drug CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Small Molecule Drug CDMO Services Market Share by Revenue, by Application (2021-2026)
Table 15. Global Small Molecule Drug CDMO Services Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Small Molecule Drug CDMO Services Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Small Molecule Drug CDMO Services Applications
Table 18. Global Small Molecule Drug CDMO Services Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Small Molecule Drug CDMO Services Market Share by Players (2021-2026)
Table 20. Global Top Small Molecule Drug CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO Services as of 2025)
Table 21. Ranking of Global Top Small Molecule Drug CDMO Services Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Small Molecule Drug CDMO Services Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Small Molecule Drug CDMO Services, Headquarters and Area Served
Table 24. Global Key Players of Small Molecule Drug CDMO Services, Product and Application
Table 25. Global Key Players of Small Molecule Drug CDMO Services, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Small Molecule Drug CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Small Molecule Drug CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 29. North America Small Molecule Drug CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Small Molecule Drug CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Small Molecule Drug CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Small Molecule Drug CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Small Molecule Drug CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Small Molecule Drug CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Small Molecule Drug CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Small Molecule Drug CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Small Molecule Drug CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Small Molecule Drug CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Small Molecule Drug CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Small Molecule Drug CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Small Molecule Drug CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Small Molecule Drug CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Small Molecule Drug CDMO Services Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Small Molecule Drug CDMO Services Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Small Molecule Drug CDMO Services Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Small Molecule Drug CDMO Services Market Size by Application (2021-2026) & (US$ Million)
Table 47. Gliead Company Details
Table 48. Gliead Business Overview
Table 49. Gliead Small Molecule Drug CDMO Services Product
Table 50. Gliead Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 51. Gliead Recent Development
Table 52. Boehringer Ingelheim Company Details
Table 53. Boehringer Ingelheim Business Overview
Table 54. Boehringer Ingelheim Small Molecule Drug CDMO Services Product
Table 55. Boehringer Ingelheim Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 56. Boehringer Ingelheim Recent Development
Table 57. Vertex Company Details
Table 58. Vertex Business Overview
Table 59. Vertex Small Molecule Drug CDMO Services Product
Table 60. Vertex Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 61. Vertex Recent Development
Table 62. Mirati Therapeutics Company Details
Table 63. Mirati Therapeutics Business Overview
Table 64. Mirati Therapeutics Small Molecule Drug CDMO Services Product
Table 65. Mirati Therapeutics Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 66. Mirati Therapeutics Recent Development
Table 67. AMPAC Company Details
Table 68. AMPAC Business Overview
Table 69. AMPAC Small Molecule Drug CDMO Services Product
Table 70. AMPAC Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 71. AMPAC Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Small Molecule Drug CDMO Services Product
Table 75. Pfizer Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Polypeptide Company Details
Table 78. Polypeptide Business Overview
Table 79. Polypeptide Small Molecule Drug CDMO Services Product
Table 80. Polypeptide Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 81. Polypeptide Recent Development
Table 82. Bachem Company Details
Table 83. Bachem Business Overview
Table 84. Bachem Small Molecule Drug CDMO Services Product
Table 85. Bachem Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 86. Bachem Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Small Molecule Drug CDMO Services Product
Table 90. Merck Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 91. Merck Recent Development
Table 92. Asymchem Company Details
Table 93. Asymchem Business Overview
Table 94. Asymchem Small Molecule Drug CDMO Services Product
Table 95. Asymchem Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 96. Asymchem Recent Development
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Small Molecule Drug CDMO Services Product
Table 100. Thermo Fisher Scientific Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 101. Thermo Fisher Scientific Recent Development
Table 102. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 103. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 104. Zhejiang Jiuzhou Pharmaceutical Small Molecule Drug CDMO Services Product
Table 105. Zhejiang Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 106. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 107. Porton Fine Chemicals Company Details
Table 108. Porton Fine Chemicals Business Overview
Table 109. Porton Fine Chemicals Small Molecule Drug CDMO Services Product
Table 110. Porton Fine Chemicals Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 111. Porton Fine Chemicals Recent Development
Table 112. Lonza Group Company Details
Table 113. Lonza Group Business Overview
Table 114. Lonza Group Small Molecule Drug CDMO Services Product
Table 115. Lonza Group Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 116. Lonza Group Recent Development
Table 117. JOINN Biologics Company Details
Table 118. JOINN Biologics Business Overview
Table 119. JOINN Biologics Small Molecule Drug CDMO Services Product
Table 120. JOINN Biologics Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 121. JOINN Biologics Recent Development
Table 122. Zhejiang Langhua Pharmaceutical Company Details
Table 123. Zhejiang Langhua Pharmaceutical Business Overview
Table 124. Zhejiang Langhua Pharmaceutical Small Molecule Drug CDMO Services Product
Table 125. Zhejiang Langhua Pharmaceutical Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 126. Zhejiang Langhua Pharmaceutical Recent Development
Table 127. Kingchem (Liaoning) Life Science Company Details
Table 128. Kingchem (Liaoning) Life Science Business Overview
Table 129. Kingchem (Liaoning) Life Science Small Molecule Drug CDMO Services Product
Table 130. Kingchem (Liaoning) Life Science Revenue in Small Molecule Drug CDMO Services Business (2021-2026) & (US$ Million)
Table 131. Kingchem (Liaoning) Life Science Recent Development
Table 132. Small Molecule Drug CDMO Services Market Trends
Table 133. Small Molecule Drug CDMO Services Market Drivers
Table 134. Small Molecule Drug CDMO Services Market Challenges
Table 135. Small Molecule Drug CDMO Services Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

List of Figures
Figure 1. Small Molecule Drug CDMO Services Product Picture
Figure 2. Global Small Molecule Drug CDMO Services Market Share by Type: 2025 vs 2032
Figure 3. Preparation Features
Figure 4. Chemical API Features
Figure 5. Global Small Molecule Drug CDMO Services Market Share by Application: 2025 vs 2032
Figure 6. Clinical Treatment
Figure 7. Medical Research
Figure 8. Commercial Production
Figure 9. Small Molecule Drug CDMO Services Report Years Considered
Figure 10. Global Small Molecule Drug CDMO Services Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 11. Global Small Molecule Drug CDMO Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Small Molecule Drug CDMO Services Market Share by Revenue, by Region: 2021 vs 2025
Figure 13. North America Small Molecule Drug CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 14. Europe Small Molecule Drug CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 15. Asia-Pacific Small Molecule Drug CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Latin America Small Molecule Drug CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Middle East & Africa Small Molecule Drug CDMO Services Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Global Small Molecule Drug CDMO Services Market Share by Players in 2025
Figure 19. Global Top Small Molecule Drug CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO Services as of 2025)
Figure 20. The Top 10 and 5 Players Market Share by Small Molecule Drug CDMO Services Revenue in 2025
Figure 21. North America Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
Figure 22. North America Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
Figure 23. Europe Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
Figure 24. Europe Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
Figure 25. Asia-Pacific Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
Figure 26. Asia-Pacific Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
Figure 27. Latin America Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
Figure 28. Latin America Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
Figure 29. Middle East & Africa Small Molecule Drug CDMO Services Market Share by Type (2021-2026)
Figure 30. Middle East & Africa Small Molecule Drug CDMO Services Market Share by Application (2021-2026)
Figure 31. Gliead Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 32. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 33. Vertex Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 34. Mirati Therapeutics Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 35. AMPAC Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 36. Pfizer Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 37. Polypeptide Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 38. Bachem Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 39. Merck Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 40. Asymchem Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 41. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 42. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 43. Porton Fine Chemicals Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 44. Lonza Group Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 45. JOINN Biologics Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 46. Zhejiang Langhua Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 47. Kingchem (Liaoning) Life Science Revenue Growth Rate in Small Molecule Drug CDMO Services Business (2021-2026)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed